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ABSTRACT 
 Cervical cancer is a prominent cancer in U.S. women caused primarily by the human 
papilloma virus and its incidence and mortality rates have decreased through screening programs. 
Certain barriers are perceived to be affecting the rates of cervical cancer screening among women 
living with HIV (WLWH). A systematic review was conducted to identify and summarize these 
barriers among WLWH nationwide. There is a need to increase awareness and education among 
WLWH. Public health programs and community-based interventions should target women of low 
SES and minority status while assessing the barriers among this population to improve cervical 
cancer screening rates. 
 




 Cervical cancer is one of the most prominent gynecological cancers ranking 14th in 
frequency in the USA (National Institutes of Health, 2010). In 2014, 12,578 women were 
diagnosed with cervical cancer and 4,115 women died from cervical cancer in the USA (U.S. 
Cancer Statistics, 2014). The age-adjusted incidence rates, per 100,000 women, for HPV-
associated cervical cancer in the USA during the years 1998-2012, was highest among Hispanics 
(9.7) compared to Non-Hispanics (7.1), The rates were higher in African-Americans (9.2) followed 
by Whites (7.1), American Indians/Alaskan Natives (6.3), and Asian/Pacific Islanders (6.1) (Viens 
et al., 2016). 
 Of the gynecologic cancers (cervical, ovarian, uterine, vaginal, and vulvar), only cervical 
cancer has a screening test. The screening tests include the Pap (Papanicolaou) test and human 
papillomavirus (HPV) test, as most cases are caused by HPV (Baseman & Koutsky, 2005). In a 
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Pap test, the sample is examined to see if the cells are atypical presenting with low-grade squamous 
intra-epithelial neoplasia [LGSIL], high-grade squamous intra-epithelial neoplasia [HGSIL] or 
atypical squamous cells of undetermined significance (ASCUS). The HPV sample is tested for the 
presence of 13–14 of the most common high-risk HPV types because cervical cancers associated 
with certain HPV types were considered to be of high risk (Musa et al., 2005). The screening tests 
can detect the cancer during early stages where the treatment can be most effective. Current 
American College of Obstetricians and Gynecologists (ACOG) guidelines recommend women 
ages 21–29 years should have a Pap test every 3 years. Women ages 30–65 years should have a 
Pap test and an HPV test (co-testing) once every 5 years, or only the Pap test once every 3 years 
(Practice Bulletin, ACOG, 2016). However, in WLWH and those with prior history of cervical 
cancer, the ACOG states that they may require more frequent cervical cancer screening and 
recommends they do not follow the routine guidelines (ACOG, n.d.). 
Cervical Cancer in WLWH 
Women living with HIV (WLWH) are at increased risk of getting HPV infection compared 
with the general adult female population (Clofford et al., 2005; Grulich et al., 2007; Bratcher and 
Sahasrabuddhe, 2010). The Canadian Women's HIV Study shows that the crude prevalence rates 
of HPV infection among WLWH was 73.6% as compared to 52.5% among WLWH (Hankins et 
al., 2000). Another study showed that women with AIDS-defining illness or with low level of 
immunity (with CD4+ T cell count <200 cells/mm3) have a six-fold increase of abnormal cytology 
of the cervix (Maiman et al., 1998). WLWH show a seven-fold increase of HPV infection 
compared to women without HIV infection (Womack et al., 2000). HPV types 16 and 18 are of 
higher oncogenic risk than the other types. WLWH are more likely to be infected with these high-
risk HPV types and are also infected with multiple HPV types than the women without HIV 
infection (Sun et al., 1997). Highly Active Anti-Retroviral Therapy (HAART) has increased the 
lifespan of WLWH; yet there is a prolonged risk of exposure to HPV putting them at higher risk 
for cervical cancer.  
Additionally, the United States Food and Drug Administration has approved three vaccines 
for prevention of HPV infections (Gardasil, Gardasil 9 and Cervarix) for girls aged 11-12 years 
and can be given up to the age of 26 years (Gillison et al., 2008). The current vaccines provide 
strong protection against new HPV infections for certain types of viral strains, but they are not 
effective at treating established HPV infections or disease caused by HPV (Hildesheim et al., 
2007). However, in WLWH, these vaccines are less robust in increasing an immune response 
(Levin et al., 2010). The HPV infection in individuals living with HIV is caused by certain strains 
of the HIV virus which are not covered by the vaccine (Heard, 2009). Therefore, it is highly 
recommended that WLWH adhere to a regular screening schedule for the early detection of 
cervical cancer. 
New guidelines were effective from 2012 as recommended by U.S. Preventive Services 
Task Force (USPSTF) for cervical cancer screening. As per the new guidelines, WLWH are 
recommended to have screening every 6 months in the first year of HIV diagnosis and annually 
thereafter (Moyer and U.S. Preventive Services Task Force, 2012). There are several barriers and 
factors influencing cervical cancer screening rates among general population such as older age, 
lower income, education level, lack of health insurance, unmarried status etc. (Datta et al., 2006). 
Several other risk factors influence cervical cancer screening rates in WLWH such as age, 
race/ethnicity, lower income, lack of health insurance, not having a regular source of primary 
health care, high viral loads, low CD4+ T cell counts, cigarette smoking and injection drug use. 
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(Baranoski et al., 2011; Chen et al., 2012; Lambert et al., 2015). The objective of this study is to 
assess and summarize the barriers and/or risk factors influencing cervical cancer screening rates 
among WLWH of the USA through a systematic review since the implementation of new 
guidelines in 2012. To our knowledge, there has been no systematic review conducted specifically 




A systematic literature review was conducted to summarize the barriers and/or risk factors 
of cervical cancer screening rates among WLWH in the USA and therefore IRB approval was 
unnecessary for this study. The databases PubMed and Cochrane Library were searched for peer-
reviewed journal articles published between January 1, 2012 and October 31, 2017. 
Inclusion Criteria 
Qualitative and quantitative studies that identify the barriers or factors influencing cervical 
cancer screening rates at the health service level or at a community level in WLWH are included 
in the systematic review. The literature search was restricted to peer-reviewed articles that are 
published in the English language that demonstrated the risk factors for receiving cervical cancer 
screening rates in WLWH. This review considered the studies limited to the USA where there are 
standard guidelines for cervical cancer screening. 
Exclusion Criteria 
Conference abstracts and unpublished manuscripts were excluded from this review due to 
difficulty in obtaining these documents or unclear demonstration of the barriers discussed above. 
Studies conducted outside of the USA, which may follow different guidelines, and articles 
published in a language other than English were excluded from this review. Finally, any previous 
systematic reviews identifying the barriers were also excluded from this review. 
Search Terms 
The search terms or key words chosen for searching the databases are (“HIV-positive 
women” or “HIV-positive females” or “HIV-infected women” or “HIV-infected females”) and 
(“cervical cancer screening” or “Pap smear test” or “Pap test” or “human papilloma virus test” or 
“HPV test”) and (“barriers” or “risk factors”).  
Retrieval of Studies 
The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
guidelines were followed in selection of the eligible articles, appraisal and during the synthesis of 
the results (Boland et al., 2014). An initial search across the PubMed and Cochrane databases was 
conducted and these citations were exported into Mendeley software and assessed for duplicates. 
The imported citations were then title screened and abstract screened considering the inclusion 
criteria. Full text articles of the included studies were reviewed for final eligibility of the studies. 
Two independent researchers completed the title screening, abstract assessment, full texts, and for 
assessment of eligibility. 
The Critical Appraisal Skills Programme (CASP) (2017a, 2017b) checklist was used for 
methodological assessment of the studies. The risk of bias for each included study was assessed 
using the Newcastle-Ottawa Scale (NOS) for non-randomized studies (Wells et al., 2013). Finally, 
a narrative synthesis of the eligible studies which have significant quality was done to know the 
effective barriers for cervical cancer screening in WLWH. 
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RESULTS 
Literature Search 
An initial search across the databases using the search terms yielded a total of 253 citations. 
After assessing for duplications, there were a total of 251 studies for title screening and abstract 
screening. Twenty-one articles were extracted after applying the inclusion and exclusion criteria 
defined above. Full text articles for the 21 studies were assessed again with the selection criteria 
for eligibility. Three articles were excluded at this point: two studies were conducted outside of 
the USA and the third one was not relevant to the aims/objectives of the systematic review. 
Eighteen articles were included in the qualitative synthesis, where one article was excluded 
because of non-relevancy to the aims of the systematic review. Seventeen articles were eligible 
and included in this systematic review for synthesis (Table 1). The entire process was represented 
in Figure 1 using the PRISMA flow diagram (Moher et al., 2009).  
 
 
The objectives, study design, study setting, outcomes, and results were examined in all 
eligible articles. Thirteen of the eligible studies are either retrospective or prospective cohort 
studies (Castle et al., 2012; Curry et al., 2012; Setse et al., 2012; Alade et al., 2017; Kim et al., 
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2013; Fletcher et al., 2014a, 2014b; Simonsen et al., 2014; Lofgren, 2015; Ogunwale et al., 2016; 
Aserlind et al., 2017; Lakshmi et al., 2017; Levinson et al., 2017). Cross et al (2014) is an 
interventional study; Frazier et al Hessol et al & Lambert et al are cross-sectional studies (Hessol 
et al., 2013; Lamert et al., 2015; Frazier et al., 2016). All of these studies were conducted either in 
a hospital or clinical setting which provides comprehensive clinical care for WLWH (Table 1).  
 
 
Table 1: Characteristics of the Included Studies: 
Study Objective Study 
Design/ 
Setting 
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*Note: Abbreviations: Women living with HIV  (WLWH), atypical squamous cells of undetermined significance 
(ASCUS), low-grade squamous intraepithelial neoplasia (LSIL), high-grade squamous intraepithelial neoplasia 
(HSIL), cervical biopsies read as grades 1, 2, or 3 Cervical Intraepithelial Neoplasia (CIN), Highly Active Anti-
Retroviral Therapy (HAART), Squamous Intraepithelial Lesions (SIL), Sexually Transmitted Infections (STI) 
** The terms, “women living with HIV” or “WLWH” were not used at the time of the initial search query as this 
preferred verbiage was more widely established subsequent to the search.  
 
Barriers or Factors that affect Cervical Cancer Screening Rates among WLWH from Eligible 
Studies 
Several barriers were identified in multiple studies which included: low income, lack of 
insurance, lower screening rates in specific populations, age groups, higher HIV viral loads, lower 
CD4+ T cell counts, lack of adherence, lack of awareness, limited transportation, pain and 
discomfort associated with pap smear testing, number of health visits, issues related to making an 
appointment, provider specific barriers, and other factors.   
Lower Income 
It was stated that forty eight percent of the WLWH did not attend follow up visits or the 
subsequent screening visits because the majority of those women (~ 80%) were below the federal 
poverty line (Aserlind et al., 2017). However, the underlying factors surrounding poverty as a 
barrier were not addressed; for example, lack of either transportation or a sliding fee scaled based 
on income. 
Lack of Insurance 
WLWH with financial and insurance limitations had low cervical cancer screening rates 
(Simonsen et al., 2014; Lakshmi et al., 2018). 
Lower screening rates in African Americans 
The African-American group of WLWH were four times non-adherent to cervical cancer 
screening than Caucasian women (Fletcher et al., 2014b). The factors reported which contribute 
to such low screening are caregiving responsibilities, lack of housing stabilities, lack of financial 
stabilities, stigma associated with the cervical cancer screening procedures and non-disclosure. 
Older Age Group 
WLWH who are of older age groups, were less likely to report to the screening services 
(Kim et al., 2013; Frazier et al., 2016). 
Higher HIV Viral Loads 
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WLWH who had higher viral loads had fewer follow up visits to regular and gynecological 
care services, thereby having lower screening rates than those with lower or undetectable HIV 
viral loads (Castle et al., 2012). 
Lower CD4+ T Cell Counts 
WLWH with lower CD4+ T cell counts (< 200 cells/μL) had lower screening rates than 
those who had higher CD4+ T cell counts (Castle et al., 2012; Setse et al., 2012; Kim et al., 2013). 
Lack of Adherence 
Those who engage in rigorous smoking and drinking habits lacked adherence to cervical 
cancer screening among WLWH (Hessol et al., 2013; Fletcher et al., 2014b). Smokers who are of 
younger age less likely to adhere to screening tests (Fletcher et al., 2014b). It was very striking to 
note that WLWH who engaged in higher amounts of alcohol consumption were five times more 
likely to fall into the non-adherence group (Fletcher et al., 2014b). 
Studies of urban clinics have demonstrated that non-adherence to the screening tests and 
follow-up care was due to low CD4+ T cell counts leading to the progression of lesions, delay in 
therapy, and insufficient treatment doses (Lofgren et al., 2015; Levinson et al., 2018). Poor 
compliance for attending the screening tests and the follow-up visits was also observed (Curry et 
al., 2012; Alade et al., 2017). WLWH without documentation of three or more CD4+ T cell counts 
and HIV viral loads along with no evidence of testing for sexually transmitted diseases in the past 
year, were less likely to report to have screening tests (Frazier et al., 2016). 
Lack of Awareness 
Studies demonstrated that there is lack of awareness about cervical cancer as a preventable 
disease among WLWH (Cross et al., 2014; Fletcher et al., 2014a). These women reported low 
knowledge about the preventive methods such as perceived susceptibility, seriousness about 
cervical cancer, barriers to screening methods, benefits, and self-efficacy (Lambert et al., 2015). 
Those who had prior atypical cervical cytology were more aware of the Pap tests or HPV tests than 
those who had no prior atypical cervical cytology (Cross et al., 2014; Ogunwale et al., 2016). 
Limited Transportation Access 
Transportation was one of the most persistent barriers for attending appointments to 
cervical cancer screening. This is especially relevant for WLWH with longer commutes to the 
clinics (Fletcher et al., 2014a). 
Pain & Discomfort Associated with Screening Tests 
Pain and discomfort caused while receiving the screening tests and with the following 
procedures act as barriers for cervical cancer screening in WLWH (Fletcher et al., 2014a). These 
women even expressed anxiety associated with undergoing follow-up procedures such as 
colposcopies, biopsies, and loop electrosurgical excision procedures (Fletcher et al., 2014a). 
Lesser Number of Health Visits 
WLWH who had lesser number of health visits were less likely to receive screening tests 
than those who had more health visits (Cross et al., 2014; Ogunwale et al., 2016). Cross et al (2014) 
demonstrates that WLWH who had a mean of 3.4 visits in a one year of time-period did not receive 
screening tests in comparison to those who had a mean of 4.2 visits (p < .01). 
Issues related to Gynecological Appointment 
Various issues related to gynecological appointments have been described (Fletcher et al., 
2014a). Some WLWH needed a referral from their primary health care provider to see a 
gynecologist or a nurse practitioner for receiving the Pap smear screening. These women reported 
dissatisfaction for having to make multiple appointments, one for regular health care, one for 
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scheduling screening tests, and one for follow-up. Some women reported excessive wait times 
associated with making and/or attending additional appointments as a barrier for adherence to 
screening tests.  
Provider-Specific Barriers 
Cross et al. (2014) has listed provider-specific barriers in addition to patient-specific 
barriers that affect the cervical cancer screening rates in WLWH at an urban clinic, including that 
providers lack training of Pap testing, lack of comfort when performing the test, and were unaware 
when patients were due for the Pap tests. It was reported that the procedures are lengthy and time-
consuming, making providers behind schedule, hence, increasing patient wait times. 
Lakshmi and colleagues (2018) outlined physician-related barriers such as lack of 
awareness of updates on screening guidelines by 21% (n=68). It was also reported that time 
allocated for the visits and procedures is not enough (reported by 43%, n=137) and the clinic lacks 
electronic system reminders regarding patient’s yearly screening tests (reported by 18%, n=58). 
Physicians also reported a lack of availability of support services required for the screening tests. 
Other Factors 
WLWH sometimes would have to focus on other health priorities rather than getting the 
screening tests as reported among 44% (n=142) of the women (Lakshmi et al., 2018). The same 
study also reported that 72% (n=232) of study participants declined the screening services 
(Lakshmi et al., 2018). Substance use and depression were other factors for not receiving screening 
tests in WLWH (Fletcher et al., 2014b; Frazier et al., 2016). Those who had high-risk behaviors 
such as intravenous drug use, having unprotected sex or multiple sexual partners were also at risk 
of not receiving regular Pap smear tests (Fletcher et al., 2014a). It was also reported that perinatally 
infected HIV-adolescents and those who are sexually active had lower screening rates than those 
behaviorally infected HIV-adolescents (Setse et al., 2012). 
 
DISCUSSION 
Application of the inclusion criteria yielded 21 studies, out of which 17 studies were 
eligible for synthesis. This was an acceptable number of pooling considering the time-frame of 5 
years (2012-2017) and limiting the studies to the USA population. All relevant research was 
included in this systematic review and conclusions were drawn based on the synthesis of available 
evidence from relevant studies based on the quality assessment criteria. Studies assessed the 
barriers that influence cervical cancer screening rates in WLWH, satisfying the aims and objectives 
of this systematic review. 
There are several barriers and factors influencing cervical cancer screening rates among 
the general population such as older age, lower income, education level, lack of health insurance, 
and unmarried status (Datta et al., 2006). The identified perceived barriers for low cervical cancer 
screening rates among WLWH through this study include lower level of knowledge of cervical 
cancer, multiple sexual partners, HIV status, high viral loads, low CD4+ T cell counts, limited 
transportation access, lack of health insurance, lack of a primary health care, pain and discomfort 
associated with receiving Pap smears, and issues related to scheduling gynecological 
appointments. These women often have poor clinical adherence and challenging social and 
financial circumstances. 
Facilitators should support to increase the knowledge and awareness regarding cervical 
cancer and maintain strong doctor-patient relationships for utilizing cervical cancer screening 
services (Fletcher et al., 2014a). One systematic review identified that one on one education was 
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useful to increase the awareness about cervical cancer and increase the screening rates by 8% 
(Sigrid et al., 2017). Some studies have shown that integration of gynecologic and general medical 
care for WLWH is important to patients and is likely to drastically improve screening rates (Oster 
et al., 2009; Sigfrid et al., s2017). The combination of automated text messaging and phone call 
reminders have been effective to improve the screening rates in the USA as well as in other parts 
of the world among WLWH (Mbuagbaw et al., 2015; Ganta et al., 2017). When provided 
incentives after undertaking screening tests, patients had positive reinforcement subsequently 
improving Pap rates, especially in groups of populations who are affected by poverty (Cross et al., 
2014). 
Most results were consistent across different studies and focused on factors that influence 
health care in WLWH. Few controversial findings were found between studies. One study reported 
lower screening rates when the WLWH were below the federal poverty line, but another study 
reported lower screening rates in those who are above the federal poverty line. (Frazier et al., 2016; 
Alade et al., 2017). However, the final results should be drawn from the studies based on the 
quality.  
There are limitations in this systematic review. The methodological quality and risk of bias 
assessment was not completed for the cross-sectional studies in this systematic review and may 
not show the relevancy of those studies. The systematic review does not include studies from grey 
literature such as conference abstracts or unpublished studies, which may miss some relevant 
studies identifying the barriers and might have a risk of publication bias. Previous systematic 
reviews attempted to identify the barriers cervical cancer screening rates in WLWH, but this 
systematic review summarizes the barriers since the implementation of new guidelines in 2012. 
The critical appraisal helped to extract and synthesize the outcomes from relevant studies, which 
makes this systematic review of high quality. The results synthesized may be generalized to the 
WLWH based on the study settings of the studies included, most of the studies are either from a 
clinic or a comprehensive HIV-care clinic representing most of HIV care services. 
This systematic review represents some of the major barriers for cervical cancer 
screening in WLWH.  Future studies should address other barriers not discussed in these studies 
including trauma, mistrust of the medical community, adverse childhood experiences, intimate 
partner violence, and urban vs. rural access to care. Future research should aim at interventions 
and public health programs that can decrease these barriers and improve the cervical cancer 
screening rates in WLWH.  
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